1. Home
  2. VSAT vs EVO Comparison

VSAT vs EVO Comparison

Compare VSAT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$32.97

Market Cap

5.1B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.22

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
EVO
Founded
1986
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
1.1B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VSAT
EVO
Price
$32.97
$3.22
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$33.00
$7.00
AVG Volume (30 Days)
2.3M
99.7K
Earning Date
11-07-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,582,796,000.00
$887,396,457.00
Revenue This Year
$5.23
N/A
Revenue Next Year
$3.15
$10.78
P/E Ratio
N/A
N/A
Revenue Growth
1.23
N/A
52 Week Low
$7.36
$2.84
52 Week High
$43.59
$5.10

Technical Indicators

Market Signals
Indicator
VSAT
EVO
Relative Strength Index (RSI) 44.41 44.46
Support Level $29.13 $2.89
Resistance Level $35.90 $3.24
Average True Range (ATR) 2.58 0.09
MACD -0.30 0.04
Stochastic Oscillator 30.63 67.39

Price Performance

Historical Comparison
VSAT
EVO

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: